Surveillance of adverse events following the introduction of inactivated poliovirus vaccine made from Sabin strains (sIPV) to the Chinese EPI and a comparison with adverse events following inactivated poliovirus vaccine made from wild strains (wIPV) in Jiangsu, China

Surveillance of adverse events following the introduction of inactivated poliovirus vaccine made from Sabin strains (sIPV) to the Chinese EPI and a comparison with adverse events following inactivated poliovirus vaccine made from wild strains (wIPV) in Jiangsu, China

One dose of inactivated poliovirus vaccine (IPV) was introduced into the Chinese Expanded Program on Immunization (EPI) in 2016. IPV made from Sabin strains (sIPV) was newly licensed in China and its safety has been concerned. This study aimed to evaluate the safety of sIPV and provide a comparison...

Full description

Bibliographic Details
Main Authors: Guodong Kang, Fenyang Tang, Zhiguo Wang, Ran Hu, Jing Yu, Jun Gao
Format: Article
Language:English
Published: Taylor & Francis Group 2021-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
vaccine safety
adverse events following immunization
inactivated poliovirus vaccines
post-marketing surveillance
expanded program on immunization
Online Access:http://dx.doi.org/10.1080/21645515.2021.1898306

Internet

http://dx.doi.org/10.1080/21645515.2021.1898306

Similar Items